Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its Alzheimer's drug donanemab, underscoring the company's advancements in a ...

California’s Gate Bioscience, a biotech developing molecular gates, a new class of small molecule drugs to eliminate ...

Gate Bioscience Inc. has entered a collaboration and license agreement with Eli Lilly and Co. to discover, develop and ...

Collaboration combines Gate Bioscience's Molecular Gate drug discovery engine with Lilly's expertise in small molecule therapeutics. Company to receive an upfront payment, an equity investment, ...

CNBC's Jim Cramer on Tuesday reviewed Figma, a design software company set to go public this week. Although he said he likes ...

Midsize U.S. metros are driving job growth, attracting talent, reshaping local economies, and offering a vibrant social scene ...

The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck research deals.

Second-year safety Calen Bullock is a standout again; the first-team offensive line starts to take shape; and rookie Kyonte ...

US President Donald Trump announced on Sunday that the United States was imposing 15-percent tariffs on all European Union ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...